Originally published by our sister publication Infectious Disease Special Edition
By Marie Rosenthal, MS
The CDC endorsed the recommendation of the Advisory Committee on Immunization Practices (ACIP) for people 65 years of age and older and certain immunocompromised individuals to receive a second dose of the 2024-2025 COVID-19 vaccine six months after their first dose.
These updated recommendations also allow people who are moderately or severely immunocompromised to get three or more